Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 126 Breast Neoplasms 78 Neoplasms 48 Prostatic Neoplasms 19 Fatigue 16 Obesity 14 Colorectal Neoplasms 13 Lung Neoplasms 11 Polycystic Ovary Syndrome 10 Colonic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Head and Neck Neoplasms 7 Weight Loss 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Multiple Myeloma 5 Lymphedema 5 Leukemia 5 Inflammation 5 Pancreatic Neoplasms 4 Overweight 4 Multiple Endocrine Neoplasia Type 1 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Insulin Resistance 4 Depression 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Stomach Neoplasms 3 Peripheral Nervous System Diseases 3

Interventions

Bevacizumab 3 Radiosurgery 2 Irinotecan 2 pembrolizumab 1 Vorinostat 1 Valproic Acid 1 Thalidomide 1 Temozolomide 1 Surveys and Questionnaires 1 Sorafenib 1 Sildenafil Citrate 1 Pliability 1 Nivolumab 1 Morphine 1 Methadone 1 Exercise 1 Equipment and Supplies 1 Eating 1 Carboplatin 1 Amifampridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neurologic Manifestations × Exercise × Clear all

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡